Abstract

High-definition endoscopy is one essential step in the initial diagnosis of inflammatory bowel disease (IBD) characterizing the extent and severity of inflammation, as well as discriminating ulcerative colitis (UC) from Crohn's disease (CD). Following general recommendations and national guidelines, individual risk stratification should define the appropriate surveillance strategy, biopsy protocol and frequency of endoscopies. Beside high-definition videoendoscopy the application of dyes applied via a spraying catheter is of additional diagnostic value with a higher detection rate of intraepithelial neoplasia (IEN). Virtual chromoendoscopy techniques (NBI, FICE, I-scan, BLI) should not be recommended as a single surveillance strategy in IBD, although newer data suggest a higher comparability to dye-based chromoendoscopy than previously assumed. First results of oral methylene blue formulation are promising for improving the acceptance rate of classical chromoendoscopy. Confocal laser endomicroscopy (CLE) is still an experimental but highly innovative endoscopic procedure with the potential to contribute to the detection of dysplastic lesions. Molecular endoscopy in IBD has taken application of CLE to a higher level and allows topical application of labeled probes, mainly antibodies, against specific target structures expressed in the tissue to predict response or failure to biological therapies. First pre-clinical and in vivo data from label-free multiphoton microscopy (MPM) are now available to characterize mucosal and submucosal inflammation on endoscopy in more detail. These new techniques now have opened the door to individualized and highly specific molecular imaging in IBD in the future and pave the path to personalized medicine approaches. The quality of evidence was stated according to the Oxford Center of evidence-based medicine (March 2009). For this review a Medline search up to January 2021 was performed using the words “inflammatory bowel disease,” “ulcerative colitis,” “crohn's disease,” “chromoendoscopy,” “high-definition endoscopy,” “confocal laser endomicroscopy,” “confocal laser microscopy,” “molecular imaging,” “multiphoton microscopy.”

Highlights

  • Gastrointestinal endoscopy plays a crucial role in patients with inflammatory bowel disease (IBD; Crohn’s disease CD; ulcerative colitis UC)

  • The exclusion or detection of intraepithelial neoplasia (IEN) is the aim of all surveillance colonoscopies in IBD to reduce the risk of malignant transformation to colorectal cancer

  • A combination of chromoendoscopy with Confocal laser endomicroscopy (CLE) can detect 5-fold higher rates of IEN compared with random biopsy protocols [3]

Read more

Summary

Frontiers in Medicine

High-definition endoscopy is one essential step in the initial diagnosis of inflammatory bowel disease (IBD) characterizing the extent and severity of inflammation, as well as discriminating ulcerative colitis (UC) from Crohn’s disease (CD). Virtual chromoendoscopy techniques (NBI, FICE, I-scan, BLI) should not be recommended as a single surveillance strategy in IBD, newer data suggest a higher comparability to dye-based chromoendoscopy than previously assumed. First pre-clinical and in vivo data from label-free multiphoton microscopy (MPM) are available to characterize mucosal and submucosal inflammation on endoscopy in more detail. These new techniques have opened the door to individualized and highly specific molecular imaging in IBD in the future and pave the path to personalized medicine approaches.

INTRODUCTION
MOLECULAR IMAGING
MULTIPHOTON MICROSCOPY
Findings
FUTURE PERSPECTIVES
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call